Research Update Mid-year 3 CHF 02323: Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy

The preparations for the CBD epilepsy study were started in December 2018, including hiring a fulltime research assistant and part-time work/study student, creating all of the study documents necessary for the trial, and creating a newsletter/announcement for Colorado veterinarians. We began enrolling patients for the study at the end of January 2018. We anticipated enrolling 20 patients per year; therefore, we are on track with 54 patients in 2 1/2 years.

Additionally, we have been working with outside clinics in Colorado to help us in the enrollment process of the study. Three local specialty clinics with board-certified neurologists are conducting the study with CSU’s oversight at their hospitals and general veterinarians are helping with the recheck appointments and blood draws. Our study has continued to gain a lot of media attention, which has helped generate interest in the study from pet owners and veterinarians. Although progress has been going well for 2 1/2 years, unfortunately, with the onset of the COVID-19 pandemic, this study has been mostly paused. We have been granted permission to continue to collect data from the dogs that were enrolled prior to the University shutdown in March, but have not been able to enroll any new patients. We have recently been approved at the College level to start enrolling once again.

Mid-Year-3 Research Update Dr. McGrath CBD treatment for epilepsy.